MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 139 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $23,000 | -90.0% | 18,865 | -74.6% | 0.00% | – |
| Q1 2017 | $229,000 | +397.8% | 74,358 | +562.7% | 0.00% | – |
| Q4 2016 | $46,000 | -70.5% | 11,220 | -54.4% | 0.00% | – |
| Q3 2016 | $156,000 | -55.4% | 24,600 | -40.2% | 0.00% | -100.0% |
| Q3 2015 | $350,000 | -54.7% | 41,166 | -39.8% | 0.00% | 0.0% |
| Q4 2014 | $772,000 | -48.2% | 68,340 | -59.7% | 0.00% | -50.0% |
| Q3 2014 | $1,490,000 | +1218.6% | 169,710 | +704.0% | 0.00% | – |
| Q4 2013 | $113,000 | +29.9% | 21,107 | -7.9% | 0.00% | – |
| Q3 2013 | $87,000 | +8.8% | 22,907 | +93.3% | 0.00% | – |
| Q2 2013 | $80,000 | – | 11,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |